Patents Assigned to ILISA TECH, INC.
  • Magnetic control of gene delivery in vivo
    Patent number: 10286073
    Abstract: This disclosure describes a composition and method of magnetic nanoparticles (MNP) that are bound to a baculovirus (BV). The MNP-BV can be systemically administered to a patient, and a strong magnetic field applied to the target tissue, thus allowing uptake and expression only in the target tissue. Off-target effects are not seen because the MNP-BC is inactivated by the complement system outside of the magnetic field.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: May 14, 2019
    Assignee: ILISA TECH, INC.
    Inventors: Haibao Zhu, Sheng Tong, Gang Bao